The Company's management believes excluding the non-cash stock compensation expense from its non-GAAP financial measures is useful for itself and investors as such expense will not result in future cash payment and is otherwise unrelated to the Company's core operating results.
The Company's management believes excluding the non-cash amortization expense of acquired intangible assets resulting from acquisitions from its non-GAAP financial measures is useful for itself and investors because they enable a more meaningful comparison of the Company's performance between reporting periods. In addition, such amortization will not result in cash settlement in the future.
The presentation of this additional financial information is not
intended to be considered in isolation or as a substitute for the financial
information prepared and presented in accordance with GAAP. For a
reconciliation of the non-GAAP financial measures to the most directly
comparable GAAP financial measure, please see the financial statements
|SOURCE China Medical Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved